Cariprazine Recruiting Phase 3 Trials for Schizophrenic Disorders Treatment

RecruitingTreatment3 IdentifierTitleDrugs
NCT03817502Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
NCT03593213Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients With Schizophrenia